Chris Lewis
Stock Analyst at Roth Capital
(1.93)
# 1,694
Out of 4,667 analysts
14
Total ratings
87.5%
Success rate
57.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chris Lewis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGNT Cognyte Software | Reinstates: Buy | $4 | $7.46 | -46.38% | 5 | Nov 8, 2017 | |
| IRMD IRADIMED CORPORATION | Reinstates: Buy | $16 | $52.08 | -69.28% | 3 | Oct 31, 2017 | |
| CUTR Cutera | Initiates: Buy | $32 | $0.30 | +10,485.51% | 1 | Jun 26, 2017 | |
| AXGN Axogen | Initiates: Buy | $15 | $12.90 | +12.40% | 1 | Mar 6, 2017 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $52.70 | - | 3 | Feb 22, 2017 | |
| IRIX IRIDEX | Initiates: Buy | $20 | $1.74 | +1,049.43% | 1 | Dec 21, 2016 |
Cognyte Software
Nov 8, 2017
Reinstates: Buy
Price Target: $4
Current: $7.46
Upside: -46.38%
IRADIMED CORPORATION
Oct 31, 2017
Reinstates: Buy
Price Target: $16
Current: $52.08
Upside: -69.28%
Cutera
Jun 26, 2017
Initiates: Buy
Price Target: $32
Current: $0.30
Upside: +10,485.51%
Axogen
Mar 6, 2017
Initiates: Buy
Price Target: $15
Current: $12.90
Upside: +12.40%
Exact Sciences
Feb 22, 2017
Upgrades: Buy
Price Target: n/a
Current: $52.70
Upside: -
IRIDEX
Dec 21, 2016
Initiates: Buy
Price Target: $20
Current: $1.74
Upside: +1,049.43%